Learn More
Invitrogen™ NALP9 Polyclonal Antibody

Description
A suggested positive control is EL4 cell lysate. PA5-21019 can be used with blocking peptide PEP-1133.
Specifications
Specifications
| Antigen | NALP9 |
| Applications | Immunohistochemistry, Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% sodium azide |
| Gene | NLRP9 |
| Gene Accession No. | Q66X03, Q7RTR0 |
| Gene Alias | CLR19.1; D7Ertd565e; NACHT, leucine rich repeat and PYD containing 9; NACHT, LRR and PYD containing protein 9; NACHT, LRR and PYD containing protein 9a; NACHT, LRR and PYD containing protein 9b; NACHT, LRR and PYD domains-containing protein 9; NACHT, LRR and PYD domains-containing protein 9A; NALP9; Nalp9a; Nalp9b; NALP-theta; NLR family pyrin domain containing 9; NLR family, pyrin domain containing 9; NLR family, pyrin domain containing 9A; NLR family, pyrin domain containing 9B; NLRP9; Nlrp9a; Nlrp9b; NOD6; Nucleotide-binding oligomerization domain protein 6; nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 9; PAN12; PYRIN and NACHT-containing protein 12 |
| Gene Symbols | NLRP9, Nlrp9a |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.